• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非局部模型在分析脑神经退行性蛋白动力学中的应用,及其在阿尔茨海默病中的应用。

Nonlocal models in the analysis of brain neurodegenerative protein dynamics with application to Alzheimer's disease.

机构信息

MS2Discovery Interdisciplinary Research Institute, Wilfrid Laurier University, Waterloo, Canada.

BCAM-Basque Center for Applied Mathematics, Bilbao, Spain.

出版信息

Sci Rep. 2022 May 5;12(1):7328. doi: 10.1038/s41598-022-11242-4.

DOI:10.1038/s41598-022-11242-4
PMID:35513401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9072437/
Abstract

It is well known that today nearly one in six of the world's population has to deal with neurodegenerative disorders. While a number of medical devices have been developed for the detection, prevention, and treatments of such disorders, some fundamentals of the progression of associated diseases are in urgent need of further clarification. In this paper, we focus on Alzheimer's disease, where it is believed that the concentration changes in amyloid-beta and tau proteins play a central role in its onset and development. A multiscale model is proposed to analyze the propagation of these concentrations in the brain connectome. In particular, we consider a modified heterodimer model for the protein-protein interactions. Higher toxic concentrations of amyloid-beta and tau proteins destroy the brain cell. We have studied these propagations for the primary and secondary and their mixed tauopathies. We model the damage of a brain cell by the nonlocal contributions of these toxic loads present in the brain cells. With the help of rigorous analysis, we check the stability behaviour of the stationary points corresponding to the homogeneous system. After integrating the brain connectome data into the developed model, we see that the spreading patterns of the toxic concentrations for the whole brain are the same, but their concentrations are different in different regions. Also, the time to propagate the damage in each region of the brain connectome is different.

摘要

众所周知,当今世界上有六分之一的人口患有神经退行性疾病。尽管已经开发出许多用于此类疾病的检测、预防和治疗的医疗设备,但相关疾病进展的一些基本原理仍迫切需要进一步阐明。在本文中,我们专注于阿尔茨海默病,据信淀粉样β和tau 蛋白的浓度变化在其发病和发展中起着核心作用。提出了一种多尺度模型来分析这些浓度在脑连接组中的传播。特别是,我们考虑了一种用于蛋白质-蛋白质相互作用的改进的杂二聚体模型。更高浓度的淀粉样β和 tau 蛋白毒性会破坏脑细胞。我们研究了这些原发性和继发性tau 病以及它们的混合传播。我们通过存在于脑细胞中的这些毒性负荷的非局部贡献来模拟脑细胞的损伤。通过严格的分析,我们检查了对应于均匀系统的稳定点的稳定性行为。将脑连接组数据整合到所开发的模型中后,我们发现整个大脑中有毒浓度的传播模式相同,但在不同区域的浓度不同。此外,在脑连接组的每个区域传播损伤所需的时间也不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/596043b222a3/41598_2022_11242_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/77a4ab293a88/41598_2022_11242_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/8f257ec4d4db/41598_2022_11242_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/3c2e33029d52/41598_2022_11242_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/c26a62ed6e59/41598_2022_11242_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/e4314b16e194/41598_2022_11242_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/6614c5b4410d/41598_2022_11242_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/d5661e3548f5/41598_2022_11242_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/c68e037fb030/41598_2022_11242_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/596043b222a3/41598_2022_11242_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/77a4ab293a88/41598_2022_11242_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/8f257ec4d4db/41598_2022_11242_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/3c2e33029d52/41598_2022_11242_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/c26a62ed6e59/41598_2022_11242_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/e4314b16e194/41598_2022_11242_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/6614c5b4410d/41598_2022_11242_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/d5661e3548f5/41598_2022_11242_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/c68e037fb030/41598_2022_11242_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0479/9072437/596043b222a3/41598_2022_11242_Fig9_HTML.jpg

相似文献

1
Nonlocal models in the analysis of brain neurodegenerative protein dynamics with application to Alzheimer's disease.非局部模型在分析脑神经退行性蛋白动力学中的应用,及其在阿尔茨海默病中的应用。
Sci Rep. 2022 May 5;12(1):7328. doi: 10.1038/s41598-022-11242-4.
2
Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease.血浆 tau/淀粉样蛋白-β1-42 比值可预测阿尔茨海默病患者的脑 tau 沉积和神经退行性变。
Brain. 2019 Mar 1;142(3):771-786. doi: 10.1093/brain/awy347.
3
Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.利福平是一种针对淀粉样β和tau 寡聚物的候选预防药物。
Brain. 2016 May;139(Pt 5):1568-86. doi: 10.1093/brain/aww042. Epub 2016 Mar 28.
4
Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Aβ and propagation of tau?PART与阿尔茨海默病之间的差异是否在于引发β淀粉样蛋白(Aβ)积累和tau蛋白扩散的脑动脉中与年龄相关的变化?
Acta Neuropathol. 2015 May;129(5):763-6. doi: 10.1007/s00401-015-1416-1. Epub 2015 Mar 27.
5
[The role of proteins in neurodegenerative disease].[蛋白质在神经退行性疾病中的作用]
Postepy Hig Med Dosw (Online). 2012 Apr 16;66:187-95. doi: 10.5604/17322693.991446.
6
Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.通过针对中心tau 表位的抗体免疫疗法预防 tau 种子和传播。
Brain. 2019 Jun 1;142(6):1736-1750. doi: 10.1093/brain/awz100.
7
Twice is better: highlights of the second meeting focused on tau biology and pathology.事不过二:第二次会议的重点聚焦于 tau 生物学和病理学。
Biochem Soc Trans. 2012 Aug;40(4):641-3. doi: 10.1042/BST20120136.
8
Tau Secretion.tau 分泌。
Adv Exp Med Biol. 2019;1184:123-134. doi: 10.1007/978-981-32-9358-8_11.
9
Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.针对阿尔茨海默病和 tau 病的磷酸化 tau 靶向小分子 PROTACs。
Biochim Biophys Acta Mol Basis Dis. 2021 Aug 1;1867(8):166162. doi: 10.1016/j.bbadis.2021.166162. Epub 2021 Apr 30.
10
Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.胰岛素缺乏促进了在阿尔茨海默病模型中与过度磷酸化 tau 寡聚体共聚集的有毒淀粉样-β42 构象体的形成。
Neurobiol Dis. 2020 Apr;137:104739. doi: 10.1016/j.nbd.2020.104739. Epub 2020 Jan 10.

引用本文的文献

1
Mathematical modelling of Alzheimer's disease biomarkers: Targeting Amyloid beta, Tau protein, Apolipoprotein E and Apoptotic pathways.阿尔茨海默病生物标志物的数学建模:针对淀粉样β蛋白、 Tau蛋白、载脂蛋白E和凋亡途径
Am J Transl Res. 2024 Jul 15;16(7):2777-2792. doi: 10.62347/UJQF5204. eCollection 2024.
2
Roles of astrocytes and prions in Alzheimer's disease: insights from mathematical modeling.星形胶质细胞和朊病毒在阿尔茨海默病中的作用:数学建模的见解。
J Biol Phys. 2024 Jun;50(2):149-179. doi: 10.1007/s10867-023-09652-0. Epub 2023 Dec 29.

本文引用的文献

1
Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers.阿尔茨海默病的疾病修饰治疗:问题多于答案。
Neurotherapeutics. 2022 Jan;19(1):209-227. doi: 10.1007/s13311-022-01201-2. Epub 2022 Feb 28.
2
In vivo rate-determining steps of tau seed accumulation in Alzheimer's disease.阿尔茨海默病中tau蛋白种子积累的体内限速步骤。
Sci Adv. 2021 Oct 29;7(44):eabh1448. doi: 10.1126/sciadv.abh1448.
3
Cellular and pathological heterogeneity of primary tauopathies.原发性 tau 病的细胞和病理学异质性。
Mol Neurodegener. 2021 Aug 23;16(1):57. doi: 10.1186/s13024-021-00476-x.
4
Pathological mechanisms and therapeutic strategies for Alzheimer's disease.阿尔茨海默病的病理机制与治疗策略
Neural Regen Res. 2022 Mar;17(3):543-549. doi: 10.4103/1673-5374.320970.
5
Landmark Alzheimer's drug approval confounds research community.具有里程碑意义的阿尔茨海默病药物获批令研究界感到困惑。
Nature. 2021 Jun;594(7863):309-310. doi: 10.1038/d41586-021-01546-2.
6
Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease.Tau 异构体在慢性创伤性脑病和阿尔茨海默病的海马体中呈现差异表达。
Acta Neuropathol Commun. 2021 May 12;9(1):86. doi: 10.1186/s40478-021-01189-4.
7
Protein-protein interactions in neurodegenerative diseases: A conspiracy theory.神经退行性疾病中的蛋白质-蛋白质相互作用:一个阴谋论。
PLoS Comput Biol. 2020 Oct 13;16(10):e1008267. doi: 10.1371/journal.pcbi.1008267. eCollection 2020 Oct.
8
Spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain and its connectome.用于朊病毒样神经退行性蛋白质在大脑及其连接组中传播动力学的空间扩展成核-聚集-碎片化模型。
J Theor Biol. 2020 Feb 7;486:110102. doi: 10.1016/j.jtbi.2019.110102. Epub 2019 Dec 3.
9
Mathematical Models to Shed Light on Amyloid-Beta and Tau Protein Dependent Pathologies in Alzheimer's Disease.数学模型解析阿尔茨海默病中淀粉样β和 Tau 蛋白依赖的病理学。
Neuroscience. 2020 Jan 1;424:45-57. doi: 10.1016/j.neuroscience.2019.09.017. Epub 2019 Nov 1.
10
Functional Geometry of Human Connectomes.人类连接组的功能几何
Sci Rep. 2019 Aug 19;9(1):12060. doi: 10.1038/s41598-019-48568-5.